Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for prevention of postoperative delirium after hip fracture surgery in older adults
ChiCTR2300072987Phase 4Recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in postoperative delirium (POD) (2 arms), sponsored by Lishui People's Hospital. Primary endpoint: Postoperative delirium. Started Jun 2023; status: recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300072987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072987.